These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19652507)

  • 1. Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Aug; 129(8):1001-5. PubMed ID: 19652507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
    Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
    den Boer E; Koch BC; Huisman R; de Jonge R
    Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
    Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
    Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
    Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method.
    den Boer E; Meesters RJ; van Zelst BD; Luider TM; Hazes JM; Heil SG; de Jonge R
    Anal Bioanal Chem; 2013 Feb; 405(5):1673-81. PubMed ID: 23239179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients.
    Hayashi H; Fujimaki C; Tsuboi S; Matsuyama T; Daimon T; Itoh K
    Tohoku J Exp Med; 2008 May; 215(1):95-101. PubMed ID: 18509240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
    Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
    Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
    Angelis-Stoforidis P; Vajda FJ; Christophidis N
    Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Takagi K; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Jul; 129(7):843-9. PubMed ID: 19571519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
    Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
    Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
    Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis.
    Pan S; Stamp LK; Duffull SB; Barclay ML; Dalrymple JM; Drake J; Zhang M; Korell J
    Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
    Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
    Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.